| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 5,513.0 | 5,143.0 |
| Gross profit | 2,224.0 | 1,990.0 |
| Profit before tax | 752.0 | 643.0 |
| Net income | 615.0 | 446.0 |
| EPS (diluted, $ a share) | $1.36 | $0.98 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +37.9% |
|---|---|
| Revenue, year on year | +7.2% |
| Gross margin | 40.3% |
| Operating margin | 14.6% |
10-Q filed with the SEC, NASDAQ: GEHC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
GE HealthCare Technologies Inc.: key numbers
- Share price
- $81.84Close, Nov 17
- Market cap
- $37B
- Shares outstanding
- 452.14MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- X-Ray Apparatus & Tubes & Related Irradiation ApparatusSIC 3844
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from GE HealthCare Technologies Inc.
All →GE HealthCare Technologies Leadership Change
Taha Kass-Hout notified GE HealthCare Technologies Inc. of his resignation as Chief Science and Technology Officer on November 4, 2026. His departure is effective December 31, 2026.
GE HealthCare Technologies Financial Results
GE HealthCare reported third quarter 2026 financial results with revenue growth of 7.2% to $5.5 billion and raised its full-year guidance. The company also announced that Jeannette Bankes will resign as President and CEO of Patient Care Solutions, to be succeeded by Neal Sandy on November 16, 2026.
“We delivered strong top-line growth and margin expansion across all segments, and robust EPS growth in the third quarter. This reflects our teams’ commercial execution, disciplined operational focus enabled by Heartbeat, and continued customer adoption of our innovations. With our improved performance year-to-date and momentum in the business, we are raising guidance for the year.”
Peter Arduini, GE HealthCare President and CEO
GE HealthCare Technologies Leadership Change
GE HealthCare Technologies Inc. has appointed Pascal Desroches, the current CFO of AT&T, to its Board of Directors effective January 4, 2027. Mr. Desroches will also serve on the Audit and Talent, Culture, and Compensation Committees, bringing over 30 years of experience in finance and corporate strategy to the board.
- Counterparty
- Pascal Desroches